Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Promisia HealthcareNZSE:PHL 33 EBITDA Margin % is 83.57% as of Mar. 2026, which is 13600% above its 10-year median of 0.61. GuruFocus rates NZSE:PHL with a GF Score™ of 33/100 and a GF Value™ of NZ$0.42 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Promisia Healthcare ranks better than 97.59% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Promisia Healthcare's EBITDA for the
six
months ended in Mar. 2026 was NZ$15.62 Mil. Promisia Healthcare's Revenue for the
six
months ended in Mar. 2026 was NZ$18.69 Mil. Therefore, Promisia Healthcare's EBITDA margin for the quarter that ended in Mar. 2026 was 83.57%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Promisia Healthcare EBITDA Margin % Related Terms
Promisia Healthcare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Promisia Healthcare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:PHL vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Promisia Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promisia Healthcare EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Promisia Healthcare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Promisia Healthcare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promisia Healthcare (NZSE:PHL) has a EBITDA Margin % of 83.57% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Promisia Healthcare and its competitors. This is 13600% above median its historical median of 0.61. According to the industry distribution chart, Promisia Healthcare ranks #16 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 2.4%.
Is Promisia Healthcare's EBITDA Margin % too high?
Promisia Healthcare's current EBITDA Margin % of 83.57% is 13600% above median its 10-year median of 0.61. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Promisia Healthcare's value of 83.57% is 718.5% above this industry median. Based on the distribution chart, Promisia Healthcare ranks #16 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Promisia Healthcare has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Promisia Healthcare's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Promisia Healthcare ranks #16 out of 664 companies for EBITDA Margin %. This places Promisia Healthcare in the top 2% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Promisia Healthcare's value of 83.57% is 718.5% above this benchmark. While the company's 10-year median is 0.61 vs. the industry median of 10.21, Promisia Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Promisia Healthcare's current EBITDA Margin % of 83.57% is 718.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Promisia Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promisia Healthcare's current EBITDA Margin % is 83.57%, which is 13600% above median its own 10-year median of 0.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisia Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Promisia Healthcare (NZSE:PHL) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$0.42, compared to a current price of NZ$0.59 — trading 40.5% above its estimated fair value. The current EBITDA Margin % is 83.57%, which is 13600% above median its 10-year median of 0.61 and 718.5% above the Healthcare Providers & Services industry median of 10.21. Promisia Healthcare's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Promisia Healthcare (NZSE:PHL), the current EBITDA Margin % is 83.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Promisia Healthcare (NZSE:PHL) Overvalued in 2026?
Based on GuruFocus' analysis, Promisia Healthcare stock appears to be overvalued.
The current stock price of NZ$0.59 is trading 40.5% above its estimated GF Value™ of NZ$0.42.
GuruFocus considers Promisia Healthcare to be Significantly Overvalued.
Key valuation signals for NZSE:PHL:
EBITDA Margin %: 83.57% (13600% above median its 10-year median of 0.61)
GF Value™: NZ$0.42 vs. price of NZ$0.59 (40.5% above fair value)
Industry Position: 718.5% above the Healthcare Providers & Services median (#16 of 664)
No single metric tells the full story. See the NZSE:PHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Promisia Healthcare Ltd is engaged in the provision of aged care in New Zealand. The company's services include Resthome Care, Hospital (Continuing) Care, Respite (Short Term) Care, Young Disabled Care, Dementia Care, and others. The Group operates in one operating segment: the provision of aged care in New Zealand.
33GF Score
Get the complete analysis for NZSE:PHL
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:PHL has been successfully added to your 
